1. Home
  2. ITRM vs LITB Comparison

ITRM vs LITB Comparison

Compare ITRM & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • LITB
  • Stock Information
  • Founded
  • ITRM 2015
  • LITB 2007
  • Country
  • ITRM Ireland
  • LITB Singapore
  • Employees
  • ITRM N/A
  • LITB N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • ITRM Health Care
  • LITB Consumer Discretionary
  • Exchange
  • ITRM Nasdaq
  • LITB Nasdaq
  • Market Cap
  • ITRM 37.7M
  • LITB 32.7M
  • IPO Year
  • ITRM 2018
  • LITB N/A
  • Fundamental
  • Price
  • ITRM $1.30
  • LITB $1.73
  • Analyst Decision
  • ITRM Strong Buy
  • LITB
  • Analyst Count
  • ITRM 1
  • LITB 0
  • Target Price
  • ITRM $5.00
  • LITB N/A
  • AVG Volume (30 Days)
  • ITRM 364.7K
  • LITB 102.7K
  • Earning Date
  • ITRM 05-12-2025
  • LITB 05-27-2025
  • Dividend Yield
  • ITRM N/A
  • LITB N/A
  • EPS Growth
  • ITRM N/A
  • LITB N/A
  • EPS
  • ITRM N/A
  • LITB N/A
  • Revenue
  • ITRM N/A
  • LITB $255,287,000.00
  • Revenue This Year
  • ITRM N/A
  • LITB N/A
  • Revenue Next Year
  • ITRM $150.10
  • LITB N/A
  • P/E Ratio
  • ITRM N/A
  • LITB N/A
  • Revenue Growth
  • ITRM N/A
  • LITB N/A
  • 52 Week Low
  • ITRM $0.81
  • LITB $0.91
  • 52 Week High
  • ITRM $3.02
  • LITB $6.00
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 56.35
  • LITB 47.83
  • Support Level
  • ITRM $1.01
  • LITB $1.65
  • Resistance Level
  • ITRM $1.42
  • LITB $2.12
  • Average True Range (ATR)
  • ITRM 0.09
  • LITB 0.21
  • MACD
  • ITRM 0.03
  • LITB -0.05
  • Stochastic Oscillator
  • ITRM 73.17
  • LITB 7.25

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: